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Drug metabolizing enzymesAbstract Trigonella foenum-graecum belongs to the family Fabaceae and is indigenous to countries
that lie on the eastern shores of the Mediterranean Sea and is also cultivated in India, Egypt and
Africa. This study provides the evidence indicating the therapeutic effect of the extract prepared
from the dried seeds of Trigonella foenum-graecum on an animal model of hepatotoxicity and on
cell proliferation. Rats were induced liver cirrhosis by thioacetamide (0.03% in water for 16 weeks).
Transmission electron microscopy of the liver tissue was done to evaluate liver cirrhosis. The herbal
extract was administered orally for 3 weeks after induction and biochemical estimations were done.
After the administration of extract the oxidative stress and lipid peroxidation were reversed. The
elevated levels of alkaline phosphatase, c-glutamyl transferase and selected biochemical markers
of liver cirrhosis including drug metabolizing enzymes were also reversed. The study has implica-
tions in ﬁnding a treatment for liver cirrhosis by a natural herbal drug with no side effects.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
The liver is one of the most important organ in the body. The
liver has important role in regulating various physiological
processes. The liver is involved in most of the biochemical
pathways for growth, ﬁghting against disease, nutrient supply,
energy provision and reproduction. It also plays a role in the
metabolism of carbohydrate, protein and fat, detoxiﬁcation,
secretion of bile and storage of vitamins (Ahsan et al., 2009).The liver helps in the removal of substances from the portal
circulation and thus makes it susceptible to ﬁrst and persistent
attack by offending foreign compounds, culminating in liver
dysfunction (Bodakhe and Ram, 2007). Liver diseases have be-
come one of the major causes of morbidity and mortality all
over the world. Among them, drug induced liver injury is
one of the most common causative factor that poses a major
clinical and regulatory challenge (Russmann et al., 2009). In
spite of tremendous scientiﬁc advancement in the ﬁeld of hepa-
tology in recent years, liver problems are in rise. Jaundice and
hepatitis are two major hepatic disorders that account for the
high death rate (Nazeema and Brindha, 2009). There are
potent indigenous herbal medicines available for the treatment
of liver disorders in various parts of the world and most of
them have not yet scientiﬁcally been validated. If they are
validated, it could lead to the development of cost effective
drugs (Jamal et al., 2009).
140 S. ZargarThe use of herbal medicines for the treatment of liver
diseases has a long history. The active chemical constituents
of liver protective plants include phenols, coumarins, monoter-
penes, glycosides, alkaloids and xanthenes (Bhawna and
Kumar, 2009). Flavonoids are phenolic compounds that are
widely distributed in plants, and have been reported to exert
multiple biological effects, including antioxidant and free rad-
ical scavenging abilities (Baek et al., 1996). Since there is lack
of modern medicine for liver disorders, a large number of
medicinal preparations are recommended for the treatment
of liver disorders (Chatterjee, 2000) and quite often claimed
to offer signiﬁcant relief. Attempts are being made globally
to get scientiﬁc evidences for these traditionally reported her-
bal drugs.
Trigonella foenum graecum Linn. is commonly known as
fenugreek and belongs to the family leguminosae. Fenugreek
is one of the most widely used plants in various indigenous
systems of medicine for the treatment of different ailments.
Trigonella foenum-graecum with common name Methi in India
is used in medicine to tonify kidneys, disperse cold and allevi-
ate pain. These seeds of herb when taken raw or toasted are a
good remedy for hernia and pain in the groin. 2–3 g of raw
fenugreek seeds early in the morning with warm water before
brushing the teeth has healing effect on joint pains, without
any side effects (Sharma et al., 1996; Warrier et al., 1995).
Other medicinal uses of Trigonella foenum-graecum include
its use as anti ulcer (Jayaweera, 1981; Al-meshal et al., 1985),
wound healing (Taranalli and Kuppast, 1996), CNS stimulant
(Natrajan et al., 2007, immunomodulatory (Bilal et al., 2003),
antioxidant (Kaviarasan et al., 2007), antidiabetic (Al-Habori
and Raman, 1988; Ravikumar and Anuradha, 1999; Zia
et al., 2001), anti-neoplastic (Sur et al., 2001), anti-inﬂamma-
tory and anti-pyretic (Ahmadiani et al., 2001) drugs. The pres-
ent study is aimed to evaluate the hepatoprotective activity
extract of fenugreek seeds against thioacetamide (TAA) in-
duced hepatotoxicity.
2. Materials and methods
2.1. Procurement of material and extraction
The dry seed of fenugreek, Trigonella foenum graecum, were
obtained from a local herbal market. The seeds were identiﬁed
and authenticated by the Herbarium of Pharmacognosy
Department, Faculty of Pharmacy, King Saud University.
Trigonella foenum-graecum seeds were dried at 40 C and ﬁnely
powdered and extracted in a Soxhlet apparatus at 60 C for 7 h
in 50% ethanol. The extracted solution was dried by
evaporation under reduced pressure in a rotary evaporator
and collected for storage at 4 C in a refrigerator until used
for further analysis. The extract was suspended in 1% gum
acacia for hepatoprotective studies.
2.2. Animals
Wistar rats (160–180 g, female), were used throughout this
study. Rats were divided into groups randomly. Animals were
provided the pellet diet and water ad libitum at temperature
22 ± 2 C and humidity at >40% with a 12-h light/dark cycle.
All animal procedures were performed in accordance with the
standards set forth in the Guidelines for the Care and Use ofExperimental Animals by the Committee for the Purpose of
Control and Supervision of Experiments on Animals (CPC-
SEA) and the National Institutes of Health (NIH). The study
protocol was approved by the Animal Ethics Committee,
College of Science, King Saud University.
2.3. Experimental design
Rats were divided into four groups, each group consisted of six
animals. Rats in group I and group II received normal drink-
ing water where group III and group IV received 0.3% TAA
dissolved in drinking water for 16 days as described by Oren
et al. (1996) to induce hepatotoxicity. One week after exposure
of TAA it was discontinued for Groups I and III and they
received normal saline, whereas, groups II and IV received
hydroalcoholic extract of Trigonella foenum-graecum seeds by
oral route, (500 mg/kg body weight, p.o suspended in 1%
gum acacia) daily for 3 weeks.
Evaluation of liver and other biochemical alterations was
performed by transmission electron microscopy and biochem-
ical parameters. At the end of experimental period, all the
animals were sacriﬁced by cervical decapitation.
2.4. Evaluation of liver function
The liver was removed, weighed and morphological changes
were observed. A 10% of liver homogenate was used for antiox-
idant studies such as lipid peroxidation (LPO), glutathione,
glutathione reductase, glutathione peroxidase, xanthine oxidase
(xod) and glutathione S transferase. Blood samples were col-
lected and allowed to clot. Serum was separated by centrifuging
at 2500 rpm for 15 min and analyzed for various biochemical
parameters that is, alkaline phosphatase (ALP) and c-glutamyl
transferase (GGT) according to the reported methods. (Nishino
et al., 2005; Mira et al., 1995; Luck, 1971).
2.4.1. Alkaline phosphatase
The serum alkaline phosphatase (ALP) activity was estimated
using a diagnostic kit (Sigma) based on the spectroscopic pro-
cedure described by Kind and King (1954).
2.4.2. Serum gamma glutamyl transferase (GGT)
GGT was measured according to the method of Orlowski and
Meister (1973). Brieﬂy, 0.2 ml serum was mixed with 0.8 ml of
substrate solution consisting of 0.528 g of 40 mM glycylgly-
cine, 0.121 g of 40 mM gamma glutamyl p-nitroanilide and
0.223 g of 11 mM MgCl2 in 100 ml of 185 mM Tris buffer at
pH 8.25. The reaction mixture was incubated for 10 min at
37 C and reaction was stopped by adding 1 ml of 25%
trichloroacetic acid. The mixture was centrifuged at 1500g
and absorbance of the supernatant was taken at 405 nm. The
enzyme activity was calculated in Eq unit/ml.
2.4.3. Lipid peroxidation (LPO)
Lipid peroxidation was determined by estimating the level of
malondialdehyde according to the method of Bernheim et al.
(1948). Brieﬂy, trichloroacetic acid is used to eliminate interfer-
ence caused by the malondialdehyde precursors. The reaction
mixture containing 1.8 ml phosphate buffer (0.1 M, pH 7.4)
and 0.2 ml tissue homogenate (10%, w/v) was incubated at
Figure 1 The section of liver from cirrhotic rat treated with
extract showed normal lobular architecture and, mitochondria are
normal and scattered, vacoules are less and macrophages sparse.
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by adding 1.0 ml of 10% trichloroacetic acid followed by
1.0 ml of 0.67% thiobarbituric acid and kept in a boiling water
bath for 20 min. Tubes containing the reaction mixture were
cooled in ice and centrifuged at 2500g for 10 min. The absor-
bance of the supernatant was taken at 432 nm against a re-
agent blank. LPO was calculated and expressed as nmol
malondialdehyde formed/mg protein at 37 C using a molar
extinction coefﬁcient of 1.56 · 105 M1 cm1.
2.4.4. Glutathione
Concentration of glutathione in the tissue sample was deter-
mined by the method of Jollow et al. (1974). Brieﬂy, 1.0 ml
of tissue homogenate was precipitated with 1.0 ml of 4%
sulfosalicylic acid, and the samples were cooled for 1 h at
4 C before centrifuging at 1200g for 15 min in a cooling cen-
trifuge. Absorbance of the assay mixture, consisting of 0.1 ml
of supernatant, 2.7 ml of phosphate buffer (0.01 M, pH 7.4)
and 0.2 ml of freshly prepared 50-dithiobis-2-nitrobenzene
(40 mg/10 ml of 0.1 M of phosphate buffer, pH 7.4) in a total
volume of 3.0 ml was taken at 412 nm. The concentration of
glutathione was expressed as lmol/g liver.
2.4.5. Glutathione reductase and peroxidase
Enzymes involved in glutathione metabolism, glutathione
reductase (GR) and glutathione peroxidase (GPx), were mea-
sured in the post mitochondrial fraction (PMF) of the tissue
by the spectrophotometric procedure described previously
(Carlberg and Mannervik, 1975). For determining the activity
of GR, the reaction mixture consisted of 1.68 ml of phosphate
buffer (0.1 M, pH 7.4), 0.1 ml of 0.1 mM NADPH, 0.1 ml of
0.5 mM EDTA, 0.05 ml of 1 mM oxidized glutathione and
70 ll of PMS (10% w/v) in a ﬁnal volume of 2.0 ml. Enzyme
activity was calculated using a molar extinction coefﬁcient of
6.22 · 103 M1 cm1 at 340 nm and expressed as nmol of
NADPH oxidized/min/mg protein. The composition of the
reaction mixture for measuring the activity of GPx was:
1.53 ml phosphate buffer (0.05 M, pH 7.0), 0.1 ml 1 mM
EDTA, 0.1 ml 1 mMNaN3, 0.1 ml 1 mM reduced glutathione,
0.1 ml 0.2 mM NADPH, 0.01 ml 0.25 mM H2O2 and 100 ll
PMF in a ﬁnal volume of 2.0 ml nmol of NADPH oxidized/
min/mg protein was calculated using a molar extinction coefﬁ-
cient 6.22 · 103 M1 cm1.
2.4.6. Xanthine oxidase (XOD),
Xanthine oxidase (XOD) is a form of xanthine oxido-reduc-
tase, a type of enzyme that generates reactive oxygen species.
These enzymes catalyze the oxidation of hypoxanthine to xan-
thine and can further catalyze the oxidation of xanthine to uric
acid. The enzyme activity was measured by the spectrophoto-
metric procedure described by Stirpe and Corte (1969). Brieﬂy,
the reaction mixture consisting of 0.2 ml of PMS (10% w/v)
diluted to 1 ml with 0.1 M phosphate buffer (pH 7.4) was
incubated at 37 C for 5 min. The reaction was initiated by
0.1 ml of xanthine and the reaction mixture was again kept
at 37 C for 20 min. The reaction was stopped by the addition
of 0.5 ml ice cold perchloric acid (10%) and diluted by adding
2.5 ml distilled water after 10 min. This mixture was centri-
fuged at 4000g for 10 min and the absorbance of the clear
supernatant was read at 290 nm. The enzyme activity was
expressed as lmol uric acid formed/mg protein.2.4.7. Glutathione S transferase
GST is a phase-II drug-metabolizing enzyme. GST was mea-
sured by the method described by Habig et al. (1974). The
assay mixture in a total volume of 3.0 ml consisted of phos-
phate buffer 0.1 M (pH 7.4), 1 mM GSH, 1 mM CDNB and
the enzyme fraction (10% w/v). The reaction was read at
340 nm and nmol CDNB conjugate formed/min/mg protein
was calculated using a molar extinction coefﬁcient of
9.6 · 103 M1 cm1.
2.5. Statistical analysis
All results are expressed as mean ± SEM. The level of signif-
icance between different groups was calculated on the basis of
analysis of variance test (ANOVA) and the drug-treated group
was compared with the rats with hepatotoxicity; P< 0.05 was
considered to be statistically signiﬁcant.
3. Results
We examined the gross organ morphology, transmission elec-
tron microscopy and biochemical changes in rats induced liver
cirrhosis with TAA for 16 days and conﬁrmed liver cirrhosis.
Gross morphology of the tissue and transmission electron
microscopy of respective samples showed the theraupeutic ef-
fect of drug extract on liver cirrhosis (Figs. 1 and 2). The liver
weight: body weight ratio was also calculated and was found to
be substantially increased in cirrhotic rats (Table 1). Morpho-
logical observations showed an increased size and enlargement
of the liver in TAA treated groups. These changes were
reversed by treatment with Trigonella foenum-graecum seed
extract at the doses tested. The levels of serum ALP and
GTT were markedly elevated in TAA treated animals, indicat-
ing liver damage. ALP levels increased by 44% in the TAA
treated group where as in the TAA treated group which re-
ceived the Trigonella foenum-graecum seed extract the eleva-
tion of ALP was markedly reduced to only 23% (Table 2).
Analysis of LPO levels by thiobarbituric acid reaction showed
Figure 2 TEM of apoptotic liver in an early phase of apoptosis
with condensed and peripheralized chromatin. The vacoulization
of cirrhotic liver is evident in ﬁgure. The arrow indicates a
fragmented section of nucleus and the most likely an apoptotic
body that seems to contain predominantly cytoplasm without
organelles or nuclear material.
142 S. Zargara signiﬁcant (P< 0.0001) increase in LPO in the TAA treated
rats. Treatment with Trigonella foenum-graecum seed extract at
500 mg/kg signiﬁcantly (P< 0.0001) prevented the increase inTable 1 Effect of test drug on liver and body weight ratio.
Group Liver weight (g)
I 06.24 ± 0.27
II 05.90 ± 0.25
III 08.92 ± 0.30
IV 09.40 ± 0.45
Data represent mean ± SEM (n= 6).
* P< 0.01 when compared to Group III. Group I: normal control, Group
and Group IV: treated with the extract after inducing with liver Cancer.
Table 2 Effect of the test drug on serum biochemical markers of li
Groups Alkaline phosphatase (ALP)
Equivalent units/ml
I 14.68 ± 0.86 (100.00)
II 14.46 ± 0.73 (098.50)
III 21.10 ± 0.93 (143.73)
IV 18.15 ± 0.69 (123.43)
Data represent mean ± SEM (n= 6). Values in bracket show percent v
control rats receiving the extract alone, Group III: cirrhotic group and G
there was about 44% increase in the activity of ALP in cirrhotic rats, incre
gamma-glutamyl transferase in treated rats was almost similar to the nor
Table 3 Effect of the test drug on the biochemical markers of oxid
Groups Lipid peroxidation (LPO) (nmol MDA formed/m
I 482.34 ± 9.99
II 508.83 ± 4.35
III 600.89 ± 8.56a
IV 544 ± 6.26a,b,c
a P< 0.0001 compared with normal Group I.
b P< 0.0001 compared with group II.
c P< 0.0001 compared with TAA Group III. Data represent mean ±LPO level which was brought to near normal. TAA treatment
caused a signiﬁcant (P< 0.0001) decrease in the level of GSH
in the liver tissue when compared with control group. Treat-
ment with Trigonella foenum-graecum seed extract at the dose
of 500 mg/kg resulted in a signiﬁcant increase of GSH when
compared to TAA treated rats (Table 3). TAA treatment
caused a signiﬁcant (P< 0.0001) decrease in the level of GR
and GPx in the liver tissue when compared with control group.
Treatment with Trigonella foenum-graecum seed extract at the
dose of 500 mg/kg resulted in a signiﬁcant increase of GR and
GPx when compared to TAA treated rats (Table 4). The drug
metabolizing enzymes XOD and GST in TAA treated group
showed a signiﬁcant (P< 0.0001) increase in their respective
levels as compared to normal control. Following Treatment
with Trigonella foenum-graecum seed extract at 500 mg/kg
signiﬁcantly (P< 0.0001) prevented the increase in xanthine
oxidase and glutathione-S-transferase levels which were
brought to near normal.
4. Discussion
The liver is one of the vital organs of the animal body and
plays a central role in transforming and clearing the chemicals,Body weight (g) Liver/bodyweight ratio (%)
266.67 ± 15.08 2.33
240.25 ± 9.08 2.45
170 ± 16.82 5.24
198 ± 8.06* 4.74
II: control rats receiving the extract alone, Group III: cirrhotic group
ver cirrhosis.
Gamma glutamyl transferase (GTT)
Nmol of p-nitroanilide/mg protein
302.00 ± 12.51 (100.00)
302.94 ± 08.79 (100.31)
359.93 ± 18.56 (119.18)
317.81 ± 07.65 (103.23)
alues with respect to Group I. Group I: normal control, Group II:
roup IV: treated with the extract after inducing liver cirrhosis. While
ase in ALP activity was about 23% in treated animals. The activity of
mal control value.
ative stress in liver cancer.
g protein) Reduced glutathione (GSH) (lmol/g tissue)
1382 ± 19.80
1358 ± 20.05
1300 ± 13.09a
1318 ± 10.62a,b,c
SEM (n= 6).
Table 4 Effect of the test drug on glutathione reductase and peroxide metabolizing enzyme glutathione peroxidase.
Groups Glutathione reductase
(nmol NADPH
oxidized/min/mg protein)
Glutathione peroxidase
(nmol NADPH
oxidized/min/mg protein)
I 527.92 ± 30.26 180.34 ± 10.33
II 523.23 ± 20.30 165.56 ± 12.34
III 416.17 ± 22.34a 134.20 ± 13.32a
IV 526.21 ± 30.36b 160.33 ± 10.20a,b
a P< 0.0001 compared with normal Group I.
b P< 0.0001 compared with TAA Group III. Data represent mean ± SEM (n= 6).
Table 5 Effect of the test drug on selected phase I and phase II drug metabolizing enzymes.
Groups Xanthine oxidase (lmol of uric acid/mg of protein) Glutathione-S-transferase (nmol of CDNB congugate/mg protein)
I 174.25 ± 05.06 653.31 ± 22.49
II 154.86 ± 09.15 640.11 ± 16.35
III 193.34 ± 04.46a 707.83 ± 08.65a
IV 158.54 ± 11.73a,b 633.03 ± 22.16b
a P< 0.0001 compared with normal Group I.
b P< 0.0001 compared with TAA Group III. Data represent mean ± SEM (n= 6).
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medicinal agents, like paracetamol, when taken in overdoses
or sometimes even within therapeutic ranges, may damage
the liver. Other chemical agents, such as those used in labora-
tories and industries, natural chemicals (e.g. microcystins) and
herbal remedies can also induce hepatotoxins. More than 900
drugs have been implicated in causing liver injury and it is one
of the most common reasons for a drug to be withdrawn from
the market Jayaweera, 1981. Products of natural origin have
been found to be effective in various types of liver disease
(Smart et al., 1986). Present study provides much evidence of
the therapeutic effect of the hydroalcoholic extract of the dried
seeds of Trigonella foenum-graecum on an animal model of
hepatotoxicity which was evaluated by various assays. Admin-
istration of Thioacetamide (TAA) has been reported to inﬂict
liver cirrhosis, depending on the period of exposure. These re-
sults were similar to the earlier reported results (Balansky
et al., 2007). The mechanism behind its toxicity is thought to
be associated with its toxic metabolite (s-oxide). It interferes
with the movement of RNA from the nucleus to the cytoplasm
which may cause membrane injury. It reduces the number of
viable hepatocytes as well as rate of oxygen consumption
and also decreases the volume of bile and its content, that is,
bile salts, cholic acid and deoxycholic acid Taranalli and Kup-
past, 1996.
In the assessment of liver damage by TAA, the enhanced
activities of these serum marker enzymes observed in TAA
treated rats in our study correspond to the extensive liver dam-
age induced by TAA. Results indicate that Trigonella foenum-
graecum seed extract administration could blunt TAA induced
increase in activities of marker enzymes of heptocellular injury,
viz. ALP, GTT suggesting that Trigonella foenum-graecum
seed extract possibly has a protective inﬂuence against TAA-
induced4.1. Heptocellular injury and degenerative changes
The improvement in the liver in rats treated with the test drug
could be because of multiple mechanisms of action of the bio-
active principles present in the hydroalcoholic drug extract.
The present study did not separate bioactive compounds be-
cause we wanted to check the effectiveness of the extract be-
fore. Future studies involve extraction of bioactive
compound in drug extract. The pharmacologically active prin-
ciples present in extract may act by inhibiting the activity of
some speciﬁc enzymes and/or ameliorating oxidative stress.
Oxidative stress and the subsequent lipid peroxidation have
been reported to initiate cirrhosis of tissues. Studies on TAA –
induced liver diseases have reported the formation of reactive
oxygen species (ROS), which initiate the peroxidation reac-
tions (Ortega et al., 1997). ROS either initiates lipid peroxida-
tion by extracting a hydrogen atom from unsaturated
membrane lipids or triggers a chain of peroxidation reactions
by reacting with the sulfhydryl compounds, that leads to cell
injury and other chronic complications. Measurement of lipid
peroxidation and reduced form of glutathione (GSH) is hence,
regarded as a biomarker of the damage caused to the tissue as
a result of excess generation of ROS or a suppressed antioxi-
dant defense. Lipid peroxidation is described as a degenerating
process in the tissue that arises from the production of free
radical reactions primarily involving membrane polyunsatu-
rated fatty acids and the production of end products such as
malondialdehyde and 4-hydroxynonenal (Ali et al., 2001). Ear-
lier reports have also shown changes in these parameters in li-
ver disease (Goodfellow and Waugh, 2009). This study
reported an increase in lipid peroxidation and a slight decrease
in the level of GSH in the liver of rats treated with TAA to in-
duce cirrhosis, and found that the extract treatment decreased
lipid peroxidation; the effect on GSH was not very signiﬁcant,
144 S. Zargaralthough the level increased slightly. Enzymes involved in
GSH metabolism were also measured in this study and it
was found that there was a decrease in the activity of GPx
and GR in cirrhotic rats, while the activity of these enzymes
increased considerably in treated rats. GPx is a particularly
important biomarker because of its ability to scavenge the
effect of peroxides produced. The activity of XOD and GST,
showed an increase in cirrhotic rats and a decrease in treated
ones (Table 5). XOD is a Mo–Fe–S ﬂavin containing hydrox-
ylase, and is reported to contribute in various forms of injury
(Ali et al., 2008). These enzymes produce ROS in catalyzing
the reaction, and therefore, an increase in its activity leads to
the oxidative stress. ROS contributes to diseases that are asso-
ciated with pulmonary vascular lesions in both relevant animal
models and humans. The drug extract might contain a bioac-
tive substance that affects the S phase of the cell cycle in some
unknown mechanism.
5. Conclusion
The present study shows that the hydroalcoholic extract pre-
pared from Trigonella foenum-graecum partially reduces liver
cirrhosis in rats by inhibiting the activity of certain enzymes,
mainly xanthine oxidase, and scavenging free radicals. Future
studies involve exploring the effect of each bioactive principle
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